The role of ibrutinib in COVID-19 hyperinflammation: A case report

Immune modulation in COVID-19 is emerging as an important therapeutic strategy as increasing evidence suggests that inflammatory pathways are implicated in lung damage. Bruton tyrosine kinase inhibitors (BTKi), such as ibrutinib, are commonly used to treat indolent B-cell neoplasms and chronic graft...

Descripción completa

Detalles Bibliográficos
Autores principales: Maynard, Suzanne, Ros-Soto, Jose, Chaidos, Aris, Innes, Andrew, Paleja, Krushika, Mirvis, Eitan, Buti, Noora, Sharp, Harriet, Palanicawandar, Renuka, Milojkovic, Dragana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885681/
https://www.ncbi.nlm.nih.gov/pubmed/33607304
http://dx.doi.org/10.1016/j.ijid.2021.02.056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885681/
https://www.ncbi.nlm.nih.gov/pubmed/33607304
http://dx.doi.org/10.1016/j.ijid.2021.02.056

Ejemplares similares